U.S. Infrastructure Stock News

NYSE:TDY
NYSE:TDYElectronic

Is Teledyne Technologies (TDY) Fairly Valued As It Buys Varex Imaging?

Teledyne Technologies (TDY) has agreed to acquire Varex Imaging in an all cash transaction valued at about US$1.1b, offering US$18.90 per Varex share. This move adds oncology focused X-ray detectors to Teledyne's portfolio. See our latest analysis for Teledyne Technologies. At a share price of US$690.25, Teledyne Technologies has posted a 30 day share price return of 8.77% and a year to date share price return of 33.06%. The 3 year total shareholder return of 71.49% points to sustained...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Oruka Therapeutics (ORKA) On Its Earnings Miss And Whether The Valuation Still Holds

Oruka Therapeutics (ORKA) drew investor attention on August 10 after reporting second quarter 2026 results that showed a wider loss per share than consensus expectations as the company continues funding its clinical pipeline. See our latest analysis for Oruka Therapeutics. The earnings miss has arrived after a strong run in Oruka Therapeutics' stock, with the latest share price at $105.14 and a year to date share price return of 271.91%. Over the past year, total shareholder return is very...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Taysha Gene Therapies (TSHA) Is Up 10.2% After Securing Long-Term TSHA-102 Manufacturing Capacity

Taysha Gene Therapies recently announced a commercial supply agreement under which Catalent will serve as the primary commercial manufacturer of TSHA-102, its investigational Rett syndrome gene therapy, at Catalent’s FDA-licensed facility in Harmans, Maryland, securing long-term GMP capacity to support potential U.S. launch and future demand. This move effectively locks in a scalable manufacturing backbone for TSHA-102, signaling that Taysha is preparing its operations for possible...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Intellia Therapeutics (NTLA) Could Be 50% Undervalued After Its Q2 2026 Earnings

Intellia Therapeutics (NTLA) reported Q2 2026 results that kept the company in loss making territory, although the net loss and loss per share for both the quarter and first half improved versus last year. See our latest analysis for Intellia Therapeutics. Intellia Therapeutics’ latest earnings release on 6 August came after a period where the stock’s year to date share price return of 30.51% is set against a 1 year total shareholder return of 11.92% and a 3 year total shareholder return that...
NYSE:EIX
NYSE:EIXElectric Utilities

Why Edison International (EIX) Is Getting Attention Today

Edison International earnings and guidance update Edison International (EIX) has released second quarter 2026 results that combine higher quarterly net income with revised, lower full year earnings guidance, giving investors fresh numbers to assess the stock. See our latest analysis for Edison International. The share price reaction around the earnings release has been weak, with Edison International down 5.1% over the past week and 9.8% over the past month, even though the year to date share...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy (EE) Could Be 17% Undervalued Following Strong Q2 Results And Dividend Hike

Excelerate Energy (EE) just reported second quarter 2026 earnings that show higher revenue and net income than the same period last year, alongside a 13% dividend increase that is drawing fresh attention to the stock. See our latest analysis for Excelerate Energy. Excelerate Energy’s recent earnings and dividend announcement come after a mixed stretch for the stock, with the share price up 25.3% year to date but easing over the past month, while the 1 year total shareholder return of 50.75%...
NYSE:NABL
NYSE:NABLSoftware

N-able (NABL) Is Down 36.6% After Lowering 2026 Revenue Guidance Amid Segment Renewal Pressure

N-able, Inc. recently reported its Q2 2026 results, shifting from a net loss of US$4.63 million a year ago to net income of US$1.76 million and issuing Q3 and full-year 2026 revenue guidance of US$134.5–US$135.5 million and US$539–US$542 million, respectively. Management highlighted Data Protection as a key driver of new annual recurring revenue and credited AI-generated code, now almost half of committed code, for improving development productivity, even as weaker renewal rates in UEM and...
NYSE:C
NYSE:CBanks

Did Citi’s New Infor Nexus–Powered Trade Platform Quietly Reframe Its Digital Strategy Narrative (C)?

Citigroup Inc. recently launched Citi Consolidate™, an Infor Nexus–powered invoice processing and supply chain finance solution now available to clients in the United States and Canada, with further country expansion planned in 2026. The new platform deepens Citi’s role in digital trade finance by combining automated invoice workflows, enhanced cash-flow visibility, and supplier financing options in a single, integrated ecosystem. We’ll now examine how Citi Consolidate™, and its push into...
NYSE:ICL
NYSE:ICLChemicals

ICL Group (ICL) Is Up 5.1% After Q2 Beat And Major Business Restructuring - What's Changed

ICL Group Ltd has reported second-quarter 2026 results showing higher sales of US$2,135 million and net income of US$137 million versus a year earlier, while also approving an organizational restructuring that will take effect on January 1, 2027 and align operations around Agriculture, Food, and Industrial end markets. The new structure elevates specialty crop nutrition and advanced food and beverage solutions as distinct focuses, reflecting management’s sharpened emphasis on higher-value,...
NYSE:ACI
NYSE:ACIConsumer Retailing

Albertsons Companies (ACI) Could Be 21% Undervalued Following Its Guidance Cut

Albertsons Companies (ACI) stock is in focus after the company cut its full year earnings guidance and missed analyst expectations, prompting a law firm investigation and speculation around potential CEO changes. See our latest analysis for Albertsons Companies. The law firm probe and questions over Albertsons Companies leadership come after a sharp reset in sentiment, with the 30 day share price return down 17.82% and the year to date share price return down 29.92%, while the 1 year total...
NYSE:POR
NYSE:PORElectric Utilities

Portland General Electric (POR) Could Be 8% Below Fair Value After Mixed Earnings

How the latest earnings frame Portland General Electric stock Portland General Electric (POR) just posted second quarter and half year 2026 results, giving you a mixed snapshot. Quarterly profit grew year over year, while revenue and net income for the first half declined. See our latest analysis for Portland General Electric. The latest earnings and regulatory filing sit against a share price that has eased recently, with the 30 day share price return down 8.85%, even though the 1 year total...
NYSE:CALY
NYSE:CALYLeisure

Callaway Golf (CALY) Lifts 2026 Sales Outlook and Buys Back Shares Is the Strategy Evolving?

Callaway Golf Company recently reported second-quarter 2026 results showing sales of US$612.2 million and net income of US$75.2 million, and it lifted full-year 2026 net sales guidance to a range of US$2.045 billion to US$2.07 billion while also issuing third-quarter sales guidance of US$415 million to US$435 million. Alongside its stronger earnings, the company repurchased 5,625,569 shares for US$80.08 million under its 2026 buyback program, signaling management’s willingness to return...
NYSE:AHR
NYSE:AHRHealth Care REITs

American Healthcare REIT (AHR) Following Its Equity Raise Has Valuation Back In Focus

American Healthcare REIT (AHR) has come into focus after completing a follow on equity offering of 13,250,000 common shares, raising about $712.2 million to help fund senior housing acquisitions and other uses. See our latest analysis for American Healthcare REIT. Alongside the follow on offering, American Healthcare REIT has seen its share price move to $55.47, with a 90 day share price return of 7.77% and a year to date share price return of 17.42% that sits against a 1 year total...
NasdaqGM:OLLI
NasdaqGM:OLLIMultiline Retail

Is Ollie’s (OLLI) Rising Price-Conscious Customer Base Quietly Reshaping Its Long-Term Value Story?

Earlier this week, Ollie’s Bargain Outlet released survey results from nearly 60,000 loyalty members for National Bargain Hunting Week, showing inflation is reshaping how customers shop and save. The findings highlight that more consumers are turning to discount retailers, carefully comparing prices, and stocking up on brand-name bargains, underscoring Ollie’s positioning as a go-to destination for value-focused shoppers. Next, we’ll examine how this evidence of rising price-consciousness...
NYSE:SCL
NYSE:SCLChemicals

Stronger Q2 Earnings And Maintained Dividend Might Change The Case For Investing In Stepan (SCL)

Stepan Company recently reported past second-quarter 2026 results showing sales of US$684.11 million and net income of US$22.91 million, alongside board and committee leadership changes and the appointment of a new Principal Accounting Officer. While quarterly earnings improved year-on-year, the company still reported a six‑month net loss of US$18.50 million, highlighting a mixed profitability picture despite the board’s decision to maintain a quarterly dividend of US$0.395 per share. We’ll...
NasdaqGS:NSIT
NasdaqGS:NSITElectronic

Insight Enterprises (NSIT) Shares Jumped, So What Is Behind The Move?

Insight Enterprises (NSIT) is back in focus after Q2 2026 results showed higher revenue, stronger earnings per share, and raised full year guidance, all tied to demand for AI infrastructure and cloud services. See our latest analysis for Insight Enterprises. The Q2 update and raised guidance have come alongside a sharp shift in sentiment, with Insight Enterprises posting a 77.82% 90 day share price return and a 24.97% 1 year total shareholder return. Momentum has clearly accelerated in recent...
NYSE:CNX
NYSE:CNXOil and Gas

Will Mixed Q2 Results and New 2026 Guidance Change CNX Resources' (CNX) Investment Narrative?

In July 2026, CNX Resources reported second-quarter results showing lower production volumes of 151.5 Bcfe and revenue of US$618.48 million compared with the prior-year quarter, while also updating its 2026 production guidance to a range of 605 Bcfe to 620 Bcfe and continuing share repurchases totaling 116.29 million shares since 2018 for US$2.13 billion. An interesting contrast emerged as quarterly revenue and net income fell year over year, yet six-month revenue and earnings per share...
NYSE:COUR
NYSE:COURConsumer Services

How Investors Are Reacting To Coursera (COUR) Surging Revenue But Growing Losses And New 2026 Guidance

In July 2026, Coursera reported second-quarter 2026 results showing sales of US$298.6 million versus US$187.1 million a year earlier, alongside a wider net loss of US$80.4 million and a basic loss per share of US$0.34 from continuing operations. At the same time, the company issued new revenue guidance of US$364 million to US$372 million for the third quarter and US$1.22 billion to US$1.25 billion for full-year 2026, highlighting management’s expectations for continued top-line expansion...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Regeneron Pharmaceuticals (REGN) Following Earnings And Buybacks, Is The Valuation Case Still Intact?

Regeneron Pharmaceuticals earnings, dividend and buybacks come into focus Regeneron Pharmaceuticals (REGN) has drawn investor attention after reporting second quarter and six month 2026 results, affirming a quarterly dividend and outlining recent share repurchases. Together, these developments shape the current stock narrative. See our latest analysis for Regeneron Pharmaceuticals. Regeneron Pharmaceuticals shares have gathered momentum this year, with a 30 day share price return of 21.6% and...
NYSE:ACN
NYSE:ACNIT

Progressive Stock And 2 Dividend Shares For Higher Income While Rates Stay Elevated

Government bond yields in major markets are holding near recent highs as central banks signal that interest rates may stay restrictive for longer. That puts dependable income front and center for many portfolios. Dividend Powerhouses with yields above 5% and well covered payouts can offer a way to seek steady cash flow when bond markets feel uncertain. This article highlights three such dividend stocks from that screener. The three stocks covered below are just a small sample of what this...
NYSE:NWN
NYSE:NWNGas Utilities

Northwest Natural Holding (NWN) Could Be 14% Undervalued On Raised 2026 Guidance

Why Northwest Natural Holding’s latest earnings matter now Northwest Natural Holding (NWN) has drawn fresh attention after releasing second quarter 2026 results and updating its full year earnings outlook. The company reported higher sales, positive net income, and guided EPS toward the upper half of its 2026 range. See our latest analysis for Northwest Natural Holding. The latest earnings and raised guidance arrive after a mixed few months for Northwest Natural Holding’s share price, which...
NasdaqGS:SWKS
NasdaqGS:SWKSSemiconductor

Skyworks Solutions (SWKS) Is Up 12.2% After Major Debt Raise And Dividend Suspension Shift To Buybacks

In early August 2026, Skyworks Solutions, Inc. completed three fixed‑income offerings totaling about US$2.00 billion across 2028, 2032, and 2036 senior unsecured callable notes, alongside an updated universal shelf registration for common stock and debt. On the same day it reported weaker third‑quarter results, Skyworks suspended its quarterly dividend and authorized up to US$2.00 billion in share repurchases through January 2029, signaling a shift toward buybacks and balance sheet...
NYSE:WT
NYSE:WTCapital Markets

WisdomTree (WT) Climbed, But What Is Behind The Fresh Attention?

Q2 earnings, dividend and buyback put WisdomTree in focus WisdomTree (WT) is back on investors' radar after its July 31 earnings release, which outlined second quarter and first half 2026 results, along with an ongoing dividend and share repurchase program. See our latest analysis for WisdomTree. WisdomTree's latest earnings, dividend affirmation, and ongoing buyback sit against a strong run in the stock, with a 30 day share price return of 15.45% and a year to date share price return of...